Skip to main content

Ringfenced radiotherapy funding

EDM (Early Day Motion) 456: tabled on 20 September 2021

Tabled in the 2021-22 session.

This motion has been signed by 19 Members. It has not yet had any amendments submitted.

Motion text

That this House is deeply concerned by the scale and severity of the covid-19 induced cancer backlog; notes Macmillan’s estimate that it will take the NHS 18 months, working at 110 per cent capacity, to clear the cancer backlog; recognises that the UK has one of the lowest cancer survivability rates in international league tables; further recognises that radiotherapy is a covid-19 safe and economical cancer treatment, costing between £4,000 and £7,000 per patient; further notes the UK’s historic underfunding of radiotherapy technologies and the woeful 27 per cent treatment rate for UK patients, in comparison to the international standard of 60 per cent; calls on the Government to support the recommendations of the APPG for Radiotherapy’s 2021 Manifesto Update; and and urges that £865 million of the new multi-billion-pound NHS funding package is ringfenced for investments which improve radiotherapy services.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.